In FY 2021, the anti-snoring devices and snoring surgery market reached a valuation of US$ 21.32 Billion, and is likely to register a Y-o-Y growth rate of 6.0% in 2022, closing at US$ 22.92 Billion. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 7.5% CAGR, reaching US$ 47.23 Billion.
Factors, such as a sedentary lifestyle, increasing consumption of alcohol and smoking, and consumption of unhealthy & processed foods are leading to a rise in the number of individuals with obesity problems.
Download Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4322
The demand of antisnoring treatments across developing countries is expected to create growth opportunities in this market. Sales have spiked in the wake of surging incidences of sleep apnea in the past few years. Sleep apnea occurs in about 25% of men and nearly 10% of women, and can affect people of all age groups.
This incidence is especially acute amongst obese people, particularly those aged above 50. Amidst the COVID-19 pandemic, anti-snoring devices experienced significant uptake, with studies concluding that patients with obstructive sleep apnea are vulnerable to adverse post-infection outcomes- such as obesity, hypertension and idiopathic pulmonary fibrosis. Increasing incidence of various sleep disorders will stimulate the global anti-snoring devices market revenue in coming years.
Key Takeaways from the Market Study
• According to Fact.MR, a CAGR of 3% was recorded for the Anti-Snoring Devices and Snoring Surgery market from 2017-2022
• In FY 2023, the Anti-Snoring Devices and Snoring Surgery market reached a valuation of US$ 22.92 Billion
• The market is likely to register a Y-o-Y growth rate of 6.0% in 2023
• By Device, the Continuous Positive Airway Pressure (CPAP) Devices Segment is expected to dominate the market, documenting a 7.3% value CAGR
• As per Fact.MR’s projections, the market for Anti-Snoring Devices and Snoring Surgery in the US will likely expand at a 7.4% CAGR
• The Anti-Snoring Devices and Snoring Surgery market in China is expected to expand at an 7.3% CAGR
Share Your Requirements & Get Customized Reports :
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4322
Competitive Landscape
Prominent players in the Anti-Snoring Devices and Snoring Surgery Industry are taking advantage of the rapidly increasing demand for the Anti-Snoring Devices and Snoring Surgery in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale players.
Some prominent market developments are as follows:
• In December 2020, Signifier, a British start-up biotechnology company announced to launch its novel Anti-Snoring device in the US market. The company aimed to reach a target funding of US$ 100 Bn for the same.
• In July 2020, Fisher & Paykel Healthcare inaugurated its 4th research and manufacturing facility at its Daniell Building in New Zealand. This expansion is expected to aid the company in continuing developing and delivering leading healthcare solutions associated with sleep disorders.• In April 2019, Zyppah received the US FDA approval to market its oral anti snoring device in the US. The company received an over-the counter device approval for marketing of the device.
Prominent Service Players
• AccuMED Corp.
• Apnea Sciences Corporation
• Fisher & Paykel Healthcare
• GE Healthcare
• ImThera Medical Inc.
• Medtronic Plc.
• Philips Healthcare
• ResMed Inc.
• SoBnoMed
• Tomed Dr. Toussaint GmbH
• Whole You, Inc.
Key Segments Covered in the Anti-Snoring Devices and Snoring Surgery Industry Survey
• Anti-Snoring Devices and Snoring Surgery by Device :
o Mandibular Advancement Anti-Snoring Devices (MAD)
o Tongue Stabilizing Anti-Snoring Device (TSD)
o Continuous Positive Airway Pressure (CPAP) Anti-Snoring Devices
o Others (Nasal and Chin Strips, Straps, Rings, etc.)
• Anti-Snoring Devices and Snoring Surgery by Surgical Procedure :
o Uvulopalatopharyngoplasty (UPPP) Snoring Surgery
o Tonsillectomy and Adenoidectomy Snoring Surgery
o Maxillo-Mandibular and Genloglossus Advancement Surgeries
o Radiofrequency Ablation (RFA) Snoring Surgery
o Pillar Procedure with Palatal Implants Snoring Surgery
Full Access to this Report Is Available:
( Christmas Offer, Get 20% 30% Discount , Hurry !!! )
https://www.factmr.com/checkout/4322
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the global Anti-Snoring Devices and Snoring Surgery market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023-2033.
Explore Fact.MR’s More Insights on the Healthcare Domain
Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html
ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Written By
The autologous fat grafting market is anticipated to witness substantial growth, with a robust compound annual growth rate (CAGR) of nearly 10% during the period from 2021 to 2031. Among various applications, breast augmentation emerges as the dominant segment, capturing a significant market share of over 45%. Autologous Fat Grafting, also known as fat transfer or lipofilling, has emerged as a ...
The osseointegration implants market is projected to witness substantial growth, with an estimated valuation of US$ 2.52 billion by the year 2022. Furthermore, this market is anticipated to expand at a robust compound annual growth rate (CAGR) of 8% and reach a sig...
The projected valuation of the trauma care centres market is estimated to reach USD 28.58 billion by the year 2032, reflecting a compound annual growth rate (CAGR) of 7.50% during the period from 2022 to 2032. Furthermore, it is anticipated that the market value of...
The drug discovery technologies market is projected to generate a revenue of US$ 59 billion in 2022, with an estimated growth to reach US$ 81.5 billion by the conclusion of 2026. This anticipated expansion is attributed to the global demand for drug discovery techn...